Nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). Fast Track designation is designed to ...

The PAUSE-URO study evaluated the safety of a new protocol for patients using direct oral anticoagulants (DOACs) prior to elective urologic surgery.

Patients with connective tissue disease-associated PAH have 1-, 3-, and 5-year survival rates similar to those with idiopathic PAH.

Pulmonary involvement is highly prevalent in individuals with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), affecting 82.7% of patients with granulomatosis with polyangiitis ...

(HealthDay News) — Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss appear to be similarly effective among adults across ages, races, and starting weights, according to a review ...

In middle-aged and older adults, anticholinergic drug burden is associated with an increased risk for cardiovascular events, according to a study published on ...

A prospective, multicenter phase 2 trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.

Patients with cancer undergoing individually tailored exercise intervention also reported less mental fatigue.

Increased vulnerability seen for adults older than 65 years, individuals with cardiac cause, those with nonshockable rhythm.

Significant interaction seen between stress trajectory group and adverse pregnancy outcomes on blood pressure. (HealthDay News) — Elevated perceived stress during and after pregnancy may contribute to ...

The FDA accepted a Biologics License Application for imlifidase for the desensitization treatment of highly sensitized adult kidney transplant patients.

Drs Uzzo, Chung, and Croll of Fox Chase Cancer Center at Temple University Health discuss top presentations from the ASCO Genitourinary Cancers Symposium 2026. The American Society of Clinical ...